Forte Biosciences, Inc.
FBRX
$6.32
-$0.34-5.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.16M | -8.39M | -12.51M | -7.42M | -5.87M |
| Total Depreciation and Amortization | 10.00K | 10.00K | 10.00K | 9.00K | 6.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 541.00K | 800.00K | 797.00K | 799.00K | 788.00K |
| Change in Net Operating Assets | -3.41M | -551.00K | 5.77M | -55.00K | -3.89M |
| Cash from Operations | -10.01M | -8.13M | -5.94M | -6.67M | -8.97M |
| Capital Expenditure | -31.00K | 0.00 | 0.00 | -6.00K | -17.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -35.96M | -- | -- | -- | 1.00K |
| Cash from Investing | -35.99M | 0.00 | 0.00 | -6.00K | -16.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.00M | 6.00K | 0.00 | 8.00K | 209.00K |
| Repurchase of Common Stock | -2.00K | -7.00K | -10.00K | -16.00K | -12.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.12M | -1.00K | -- | -- | -272.00K |
| Cash from Financing | 51.88M | -2.00K | -10.00K | -8.00K | -75.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.88M | -8.14M | -5.95M | -6.68M | -9.06M |